CPhI makes it easy for pharma to implement charity into CSR strategy
1 July 2015 | By Victoria White
CPhI Worldwide is calling on all its attendees, exhibitors and the wider pharma community to help it in its latest project with CPhI Angels...
List view / Grid view
News
Teva launches Seasonique extended-regimen contraceptive in first European markets
1 July 2015 | By Victoria White
Teva Europe has announced the first European launches of its extended-regimen oral contraceptive, Seasonique for the prevention of pregnancy...
Boehringer Ingelheim and Vitae type 2 diabetes drug misses endpoint
1 July 2015 | By Victoria White
Vitae has announced top-line efficacy results from the metformin arm of a trial of BI187004/VTP-34072 in the treatment of patients with type 2 diabetes...
St John’s Wort warning for treatment of depression
1 July 2015 | By Victoria White
St John’s Wort, a herbal medicine used in the treatment of depression, has been found to cause the same adverse reactions as prescription antidepressants...
Cuba becomes the first country to eliminate mother-to-child transmission of HIV and syphilis
1 July 2015 | By Victoria White
Cuba has become the first country in the world to receive validation from WHO that it has eliminated mother-to-child transmission of HIV and syphilis...
Repeated courses of antibiotics may alter a child’s development
A study by NYU Langone Medical Centre researchers adds to growing evidence that multiple courses of commonly used antibiotics may have a significant impact on children's development.
Intercept submits applications for marketing approval of obeticholic acid for the treatment of PBC
30 June 2015 | By Victoria White
Intercept Pharmaceuticals has achieved two important regulatory milestones for obeticholic acid in primary biliary cirrhosis (PBC)...
Virus-carrying mosquitoes are more widespread than ever
30 June 2015 | By Victoria White
Scientists behind the first global distribution maps of two species of dengue and chikungunya-carrying mosquitoes warn they are spreading to new areas...
Cardiovascular safety trial of sitagliptin met primary endpoint in patients with type 2 diabetes
30 June 2015 | By Victoria White
MSD recently announced the primary results of the TECOS trial, a placebo-controlled study of the cardiovascular safety of MSD’s DPP-4 inhibitor, sitagliptin...
Global biosimilars market value could hit $55 billion by 2020, says GBI Research
30 June 2015 | By Victoria White
The global biosimilars market value is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, according to GBI Research...
Ocrelizumab significantly reduced both relapses and disability progression in two Phase III studies in MS
30 June 2015 | By Victoria White
Roche has announced positive results from two studies evaluating ocrelizumab compared with interferon beta-1a in people with relapsing multiple sclerosis...
Phase 3 study of Emend for Injection regimen met primary endpoint
29 June 2015 | By Victoria White
Merck has announced results from a Phase 3 study investigating single-dose Emend for Injection for the prevention of CINV associated with MEC...
Next-generation system redefines performance for GC-MS Applications
Laboratories performing food safety and authenticity, pharmaceutical, metabolomic, anti-doping and other analyses using gas chromatography-mass spectrometry (GC-MS) can now achieve new levels of performance using high-resolution accurate-mass (HRAM) Orbitrap mass spectrometry, bringing the highest level of detection and identification capabilities to GC-MS studies.
New Tribrid Mass Spectrometer from Thermo Scientific
New Tribrid Mass Spectrometer with improved sensitivity redefines the limits of protein and small molecule quantitation and characterization...
New high purity grade of solvents for UHPLC-MS instrumentation
New, exceptionally pure mobile phase solvents for ultra-high-performance liquid chromatography–mass spectrometry (UHPLC-MS) instruments have been designed to reduce background signal and minimize chromatographic interferences, facilitating accurate, sensitive and rapid trace analysis.
